Home Conferences Contact Us Continuing Education Jobs Weekly News Archives Readership Profile

Monthly News Archives Pharmacy Awards Search Site Search Magazine Archives Submit a Classified Advertisement



News for week ending 26 July 2002


The Family Planning Association is looking for 300 women for a four year study with a vaccine intended to prevent infection with human papillomavirus - the virus that causes most cervical cancer.

Developed by Merck Sharp and Dohme, the vaccine has already been received by 2,700 women worldwide in phase one and phase two clinical studies.

The New Zealand women being recruited will be among 5000 in 13 countries taking part in this major phase three study.

The four main types of human papillomavirus are responsible for cervical cancer and genital warts. It is estimated that more than half of all sexually active adults will be infected with this virus at some stage in their life.

Back to welcome page

Back to news archives


Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here
For the answers to last month's quiz click here.


Click here to find out who the winners are for the Pharmacy Today/Zuellig Pharma Pharmacy Awards 2002. Also view and purchase photos of the Awards.


For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.


To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.

Job vacancies, items for sale, business opportunities and more.
Updated weekly.
click here.

Consumer Health Information

New Zealand Doctor Online